SG10201913001SA - Novel heterocyclic antiestrogens - Google Patents
Novel heterocyclic antiestrogensInfo
- Publication number
- SG10201913001SA SG10201913001SA SG10201913001SA SG10201913001SA SG10201913001SA SG 10201913001S A SG10201913001S A SG 10201913001SA SG 10201913001S A SG10201913001S A SG 10201913001SA SG 10201913001S A SG10201913001S A SG 10201913001SA SG 10201913001S A SG10201913001S A SG 10201913001SA
- Authority
- SG
- Singapore
- Prior art keywords
- antiestrogens
- novel heterocyclic
- heterocyclic
- novel
- heterocyclic antiestrogens
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN4058MU2015 | 2015-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201913001SA true SG10201913001SA (en) | 2020-03-30 |
Family
ID=58629986
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201913001SA SG10201913001SA (en) | 2015-10-27 | 2016-10-26 | Novel heterocyclic antiestrogens |
| SG11201803119XA SG11201803119XA (en) | 2015-10-27 | 2016-10-26 | Novel heterocyclic antiestrogens |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201803119XA SG11201803119XA (en) | 2015-10-27 | 2016-10-26 | Novel heterocyclic antiestrogens |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US10865199B2 (sr) |
| EP (2) | EP3368519B1 (sr) |
| JP (2) | JP6855475B2 (sr) |
| KR (1) | KR20180088375A (sr) |
| CN (1) | CN108699021B (sr) |
| AU (1) | AU2016347679B2 (sr) |
| BR (1) | BR112018008375B1 (sr) |
| CA (1) | CA3001958A1 (sr) |
| DK (1) | DK3368519T3 (sr) |
| EA (1) | EA034131B1 (sr) |
| ES (1) | ES2916223T3 (sr) |
| HR (1) | HRP20220640T1 (sr) |
| HU (1) | HUE059386T2 (sr) |
| IL (2) | IL283559B (sr) |
| LT (1) | LT3368519T (sr) |
| MX (1) | MX2018005305A (sr) |
| PH (1) | PH12018500829A1 (sr) |
| PL (1) | PL3368519T3 (sr) |
| PT (1) | PT3368519T (sr) |
| RS (1) | RS63217B1 (sr) |
| SA (1) | SA518391423B1 (sr) |
| SG (2) | SG10201913001SA (sr) |
| SI (1) | SI3368519T1 (sr) |
| UA (1) | UA122348C2 (sr) |
| WO (1) | WO2017072792A1 (sr) |
| ZA (1) | ZA201802615B (sr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6855475B2 (ja) * | 2015-10-27 | 2021-04-07 | スン プハルマ アドバンセド リサーチ カンパニー リミテド | 新規ヘテロ環状抗エストロゲン剤 |
| US10118910B2 (en) | 2015-12-09 | 2018-11-06 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective estrogen receptor downregulators |
| WO2018081168A2 (en) | 2016-10-24 | 2018-05-03 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective mixed estrogen receptor downregulators |
| TWI823845B (zh) | 2017-01-06 | 2023-12-01 | 美商G1治療公司 | 用於治療癌症的組合療法 |
| CA3052810A1 (en) | 2017-02-10 | 2018-08-16 | G1 Therapeutics, Inc. | Benzothiophene estrogen receptor modulators |
| PE20221588A1 (es) * | 2019-07-22 | 2022-10-10 | Sun Pharma Advanced Res Co Ltd | Degradador selectivo del receptor de estrogeno |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| DE69023906T2 (de) | 1990-08-09 | 1996-04-11 | Council Scient Ind Res | Benzopyrane und Verfahren zu deren Herstellung. |
| US6060503A (en) | 1991-12-02 | 2000-05-09 | Endorecherche, Inc. | Benzopyran-containing compounds and method for their use |
| US5407947A (en) | 1993-11-05 | 1995-04-18 | Eli Lilly And Company | Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans |
| US5389646A (en) | 1993-12-30 | 1995-02-14 | Zymogenetics, Inc. | Methods for treatment and prevention of bone loss using 2,3-benzopyrans |
| US5916916A (en) * | 1996-10-10 | 1999-06-29 | Eli Lilly And Company | 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods |
| WO1999002512A1 (en) | 1997-07-09 | 1999-01-21 | Novo Nordisk A/S | Dl-2,3-diaryl-2h-1-benzopyrans |
| DE10013782A1 (de) * | 2000-03-15 | 2001-10-18 | Schering Ag | 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
| WO2004091488A2 (en) | 2003-04-14 | 2004-10-28 | Merck & Co., Inc. | Estrogen receptor modulators |
| CA2595477A1 (en) * | 2005-01-21 | 2006-07-27 | Janssen Pharmaceutica N.V. | Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| US20100317635A1 (en) * | 2009-06-16 | 2010-12-16 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
| US8703810B2 (en) * | 2010-06-10 | 2014-04-22 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
| AU2012351942B2 (en) | 2011-12-14 | 2017-07-06 | Seragon Pharmaceuticals, Inc. | Fluorinated estrogen receptor modulators and uses thereof |
| AP2014007657A0 (en) | 2011-12-16 | 2014-05-31 | Olema Pharmaceuticals Inc | Novel benzopyran compounds, compositions and uses thereof |
| WO2014203132A1 (en) | 2013-06-19 | 2014-12-24 | Olema Pharmaceuticals, Inc. | Substituted benzopyran compounds, compositions and uses thereof |
| MX2015016171A (es) | 2013-06-19 | 2016-08-08 | Seragon Pharmaceuticals Inc | Moduladores del receptor de estrogeno de azetidina y usos de los mismos. |
| EP3010501B1 (en) | 2013-06-19 | 2021-11-03 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulator and uses thereof |
| US20160175284A1 (en) | 2014-12-18 | 2016-06-23 | Genentech, Inc. | Estrogen receptor modulators and uses thereof |
| EP3303326B1 (en) | 2015-05-26 | 2020-12-16 | H. Hoffnabb-La Roche Ag | Heterocyclic estrogen receptor modulators and uses thereof |
| JP6855475B2 (ja) * | 2015-10-27 | 2021-04-07 | スン プハルマ アドバンセド リサーチ カンパニー リミテド | 新規ヘテロ環状抗エストロゲン剤 |
-
2016
- 2016-10-26 JP JP2018521529A patent/JP6855475B2/ja active Active
- 2016-10-26 SG SG10201913001SA patent/SG10201913001SA/en unknown
- 2016-10-26 LT LTEPPCT/IN2016/050364T patent/LT3368519T/lt unknown
- 2016-10-26 HR HRP20220640TT patent/HRP20220640T1/hr unknown
- 2016-10-26 UA UAA201805396A patent/UA122348C2/uk unknown
- 2016-10-26 EA EA201890981A patent/EA034131B1/ru unknown
- 2016-10-26 RS RS20220454A patent/RS63217B1/sr unknown
- 2016-10-26 WO PCT/IN2016/050364 patent/WO2017072792A1/en active Application Filing
- 2016-10-26 EP EP16859220.2A patent/EP3368519B1/en active Active
- 2016-10-26 PT PT168592202T patent/PT3368519T/pt unknown
- 2016-10-26 US US15/770,824 patent/US10865199B2/en active Active
- 2016-10-26 BR BR112018008375-5A patent/BR112018008375B1/pt active IP Right Grant
- 2016-10-26 KR KR1020187012256A patent/KR20180088375A/ko not_active Application Discontinuation
- 2016-10-26 IL IL283559A patent/IL283559B/en unknown
- 2016-10-26 DK DK16859220.2T patent/DK3368519T3/da active
- 2016-10-26 PL PL16859220T patent/PL3368519T3/pl unknown
- 2016-10-26 SG SG11201803119XA patent/SG11201803119XA/en unknown
- 2016-10-26 HU HUE16859220A patent/HUE059386T2/hu unknown
- 2016-10-26 AU AU2016347679A patent/AU2016347679B2/en active Active
- 2016-10-26 CN CN201680072702.8A patent/CN108699021B/zh active Active
- 2016-10-26 SI SI201631534T patent/SI3368519T1/sl unknown
- 2016-10-26 CA CA3001958A patent/CA3001958A1/en active Pending
- 2016-10-26 ES ES16859220T patent/ES2916223T3/es active Active
- 2016-10-26 EP EP22164031.1A patent/EP4043438A1/en active Pending
- 2016-10-26 MX MX2018005305A patent/MX2018005305A/es unknown
-
2018
- 2018-04-18 PH PH12018500829A patent/PH12018500829A1/en unknown
- 2018-04-19 ZA ZA2018/02615A patent/ZA201802615B/en unknown
- 2018-04-24 SA SA518391423A patent/SA518391423B1/ar unknown
- 2018-04-26 IL IL258949A patent/IL258949B/en active IP Right Grant
-
2020
- 2020-10-28 US US17/082,488 patent/US11465990B2/en active Active
-
2021
- 2021-03-17 JP JP2021043019A patent/JP7052111B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201521109D0 (en) | Novel compounds | |
| GB201516243D0 (en) | Novel compounds | |
| GB201506871D0 (en) | Novel compounds | |
| GB201506872D0 (en) | Novel compounds | |
| AP2016009297A0 (en) | Novel heterocyclic compounds | |
| GB201501462D0 (en) | Novel compounds | |
| GB201522179D0 (en) | Novel compounds | |
| IL283559A (en) | New heterocyclic anti-estrogens | |
| GB201521751D0 (en) | Novel uses | |
| GB201505799D0 (en) | Stabilisers | |
| GB201504565D0 (en) | Novel compounds | |
| IL253635A0 (en) | Cyclopropanebenzofuranyl pyridopyrazinedione type compounds | |
| RS60264B1 (sr) | Novo heterociklično jedinjenje | |
| GB201502675D0 (en) | Novel compounds | |
| IL254890B (en) | The tercyclic compound | |
| GB201521749D0 (en) | Novel compounds | |
| GB201521713D0 (en) | Novel compounds | |
| AU365006S (en) | Top | |
| AU365005S (en) | Top | |
| AU365007S (en) | Top | |
| AU365004S (en) | Top | |
| AU365011S (en) | Top | |
| AU365016S (en) | Top | |
| GB201516241D0 (en) | Novel compounds | |
| GB201512829D0 (en) | Novel compounds |